18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma

Clinical Nuclear Medicine

Volumn 37, Issue 5, 2012, Pages 492-494

  Cao, Qi ^a   Lu, Minh ^a   Heath, Jonathon ^a   Hausner, Petr F ^a   Alexander, H Richard ^a   Dilsizian, Vasken ^a   Chen, Wengen ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

FDG PET CT; peritoneal mesothelioma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; LAPAROTOMY; PERITONEUM MESOTHELIOMA; RECURRENT CANCER; MESOTHELIOMA; MIDDLE AGED; PERITONEUM TUMOR; RADIOGRAPHY; SCINTISCANNING; TUMOR RECURRENCE;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MESOTHELIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;

EID: 84859648401     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182478bb5     Document Type: Article

References (10)

1. Davidson B, Risberg B, Berner A, et al. The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma. Semin Diagn Pathol. 2006;23:35-43. (Pubitemid 44430047)
2. de Pangher Manzini V. Malignant peritoneal mesothelioma. Tumori. 2005; 91:1-5.
3. Kamp DW. Asbestos-induced lung diseases: an update. Transl Res. 2009; 153:143-152.
4. Rudd RM. Malignant mesothelioma. Br Med Bull. 2010;93:105-123.
5. Sebbag G, Yan H, Shmookler BM, et al. Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg. 2000;87:1587-1593.
6. Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003;21:4560-4567. (Pubitemid 46594027)
7. Ponce Lorenzo J, Gimeaposnez Ortiz A, Aparisi F, et al. Peritoneal mesothelioma: an inusual clinical presentation in a patient without exposure to asbestos [in Spanish]. An Med Interna. 2007;24:81-83. (Pubitemid 350092930)
8. Noguchi T, Kawamura M, Kawamura T, et al. A case of diffuse peritoneal malignant mesothelioma - intraabdominal administration of cisplatin is useful for diminishing ascites [in Japanese]. Gan To Kagaku Ryoho. 2010;37:1975-1978.
9. Banayan S, Hot A, Janier M, et al. Malignant mesothelioma of the peritoneum as the cause of a paraneoplastic syndrome: detection by 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2006;33:751. (Pubitemid 43852888)
10. Eade TN, Fulham MJ, Constable CJ. Primary malignant peritoneal mesothelioma: appearance on F-18 FDG positron emission tomographic images. Clin Nucl Med. 2002;27:924-925.